Havas Health & You Launches Global Customer Experience Network, Havas Health CX
NSF renews Rice-based NEWT Center for water treatment
Repurposing drugs for a pan-coronavirus treatment
Novel antiviral strategy for treatment of COVID-19
New study to assess pandemic’s impact on Canadian veterans and their spouses
The rise of ‘zoom towns’ in the rural west
INRS invests $1 million in research on COVID-19 to respond to society’s urgent needs
To Vaccinate or not?
Regeneron Scores FDA Nod For Ebola Treatment
WHO Europe Director Says Governments Should Stop Enforcing Lockdowns
Vertex Sinks 12% On Halt of VX-814 Development; Merrill Lynch Says Buy
Could an existing vaccine make COVID-19 less deadly? Mexico City study provides support
Protein that keeps immune system from freaking out could form basis for new therapeutics
Collaboration earns $1.35 million grant to reduce impact of substance abuse in Appalachia
Army researchers collaborate on universal antibody test for COVID-19
Excluding pregnant women from COVID-19 vaccine trials puts their health at risk
New blood test predicts which COVID-19 patients will develop severe infection
Immune failure can cause serious COVID-19
Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels
UnitedHealth Reports 3Q Profit Beat Led By Optum Growth
Futures, Global Markets Unsure What To Do As "Angst" Rises
Tourism suffers again on the stock market due to delays in vaccines against the coronavirus
How do pandemics end? History suggests diseases fade but are almost never truly gone
Dementia deaths rise during the summer of COVID, leading to concern
Drug deaths in England and Wales rise for eighth consecutive year
Coronavirus re-infection case confirmed in the US
Clear COVID health information essential for return to normal healthcare – report
Eli Lilly pauses trial of Covid-19 antibody drug over safety concern
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
News briefing: Regeneron/Sanofi post positive PhIII Dupixent data in pediatric asthma; Vineti scores $33M Series C extension